Post Acute Care

Post-Acute Care facilities offer patients requiring significant medical support a transition between the acute care hospital and home or chronic care. Patients are discharged from acute care hospitals to post-acute care facilities when they require more complex care than they can receive from family at home, but less complex and less expensive care than what is delivered in an acute care hospital. Post-acute care facilities provide continuing care for patients recovering from acute illness, injury or exacerbation of a chronic disease. The most common types of post-acute care facilities are Long Term Acute Care Hospitals (LTACH), Skilled Nursing Facilities (SNF) and Inpatient Rehabilitation Facilities (IRF).

Vapotherm High Flow Therapy Treatment

Ventilator and Tracheostomy Weaning

Vapotherm heated and humidified high flow therapy can be an effective tool throughout the ventilator and tracheostomy weaning process, primarily by providing humidified oxygen through the trach collar/mask to mobilize secretions but also as gentle respiratory support during capping trials.

Tracheostomy Humidification– During spontaneous breathing trials, Vapotherm delivers precise FiO2 at body temperature and humidity to the trach collar/mask, aiding in the mobilization of secretions and airway clearance.

Respiratory Support– During capping trials, only the Vapotherm patient interface need to be changed from a trach adapter to a nasal cannula to continue to support the patient's supplemental oxygen requirements with optimally heated and humidified gas.

Pulmonary Rehabilitation– The Vapotherm Transfer Unit (VTU) allows for patient ambulation while on Vapotherm therapy. Whether sitting in a chair, walking the hallways or exercising in the gym, the patient receives the same precise heated and humidified oxygen as they do in bed.

Respiratory Support for Acute Respiratory Distress

Vapotherm can be used as both a rescue and weaning therapy for non-tracheostomy patients that experience acute respiratory distress to avoid more invasive interactions such as NIPPV or mechanical ventilation. Vapotherm efficiently delivers oxygen levels from 21-100% while flushing the upper airway of carbon dioxide, reducing the patient's work of breathing between 11-13%. It does this through a nasal cannula, allowing the patient to comfortably eat, speak and sleep while receiving a high level of respiratory support.

Dyspnea Relief

Vapotherm High Flow Therapy (HFT) helps to reduce symptoms of dyspnea by addressing the underlying causes:

Hypoxia (i.e. deficiency in the amount of oxygen reaching the tissues)
– Vapotherm can deliver precise fractional levels of oxygen from 21-100%.

Hypercapnia (i.e. excessive carbon dioxide in the blood stream.)
–Vapotherm continually flushes the upper airway with fresh gas to reduce/eliminate the amount of carbon dioxide inhaled with each breath.

The breathing gas delivered by the Vapotherm system is optimally heated and humidified providing a comfortable therapy even at high flow rates. The ideally conditioned gas prevents increased airway resistance caused by drying and inflammation of the upper airway and mobilizes secretions in the airway. The therapy is delivered via a nasal cannula, allowing the patient to comfortably eat, speak and sleep.

A recent study conducted by MD Anderson in Houston indicates that HFT also may effectively improve symptoms of persistent dyspnea in end stage cancer patients already being treated with current standard of care (i.e. opioids and supplemental oxygen).

Post-Acute Care Centers of Excellence

See how Post-Acute Care Hospitals today are best realizing the potential of Vapotherm technology as part of their efforts to improve patient care and outcomes while maximizing the effectiveness and efficiency of facility staff and resources.
Learn about how Gaylord Hospital, a Vapotherm Center of Excellence, uses Vapotherm High Flow Therapy.